The FDA has received reports of T-cell malignancies in patients who have been treated with CD19- or BCMA-directed autologous CAR T-cell immunotherapies.
As per the report by Fortune Business Insights, the global CAR-T Cell Therapy Market size is projected to reach USD 14.42 billion in 2030, at a CAGR of 18.5% during the forecast period, 2023-2030 CAR-T Cell Therapy Market Forecast 2023-2030 Pune, India, Sept. 25, 2023 (GLOBE NEWSWIRE) Global CAR-T Cell Therapy Market Size was valued at USD 2.72 billion in 2022 and is projected to grow from USD 14.42 billion by 2030 exhibiting a CAGR of 18.5% during forecast period. The growing prevalence of c